Bristol-Myers Squibb

Child Organization: Convatec

Bristol-Myers Squibb (NYSE: BMY), often referred to as BMS, is a pharmaceutical company, headquartered in New York City. The company was formed in 1989, following the merger of its predecessors Bristol-Myers and the Squibb Corporation. Squibb was founded in 1858 by Edward Robinson Squibb in Brooklyn, New York, while Bristol-Myers was founded in 1887 by William McLaren Bristol and John Ripley Myers in Clinton, New York (both were graduates of Hamilton College).

Source: Wikipedia

Campaign Finance

Information

Figures are based on itemized contributions reported to the Federal Election Commission and state agencies. Please note that:

  • contributions under $200 are not reported, and so are not included in totals.
  • only contributions from individuals and organizations to candidates are included. Various accounting measures and more exotic contribution types are excluded.
  • contributions are matched based on organization and recipient name reported within each election cycle. Contributions using an incorrect or non-standard version of the name may be missed.
  • corporate name changes and mergers may cause figures to differ from those of the Center for Responsive Politics.
  • organization totals include known subsidiaries of the organization.

For more information, please see our campaign finance methodology page. Lobbyist bundling data is described on our lobbyist bundling methodology page.

Latest FEC Data

covers through committee's May 31, 2012 filing.
Download all contributions to Bristol-Myers Squibb

  • Summary

    overview of the committee's finances
    Total Raised:
    $126,800
    Total Spent:
    $101,209
    Cash on Hand:
    $56,543
    Debts:
    $0

Standardized Donation Information

covers through 2011. may lag behind FEC section above, as donors and industries are identified by hand.

  • Top Recipients

    Employee Color Block
    Individuals
    PAC Color Block
    PAC
    Includes contributions from the organization’s employees, their family members, and its political action committee.

  • Republicans vs. Democrats

    in dollars. "Other" includes 3rd parties and organizations without official party affiliation.

  • State vs. Federal

    in dollars

  • Top PAC Recipients

    Employee Color Block
    Individuals
    PAC Color Block
    PAC
    Includes contributions from the organization’s employees, their family members, and its political action committee.
View all campaign finance data for Bristol-Myers Squibb Sources: OpenSecrets.org FollowTheMoney.org

Lobbying

$2,260,000 Spent
Information

Figures are based on lobbying activity reported to the Senate Office of Public Records. Reported dollar amounts are required to be accurate only to the nearest $20,000. For organizations whose primary business is lobbying, we display total income and top clients. For organizations that are not primarily lobbying firms, we display total amount spent on lobbying and top lobbying firms hired.

For more information, please see our lobbying methodology page.

covers through Q3, 2011

Lobbying On Behalf of Bristol-Myers Squibb

View all lobbying data for Bristol-Myers Squibb Sources: Lobbyist Registration Tracker OpenSecrets.org

Regulations

13 Mentions; 3 Submissions
Information

All data is based on documents downloaded from Regulations.gov. The first table shows mentions: all documents that include the name of the company anywhere in the document or document metadata. The second table shows submissions: all documents where the submitter metadata included the company name. Each table shows the top 10 dockets, ranked by number of occurrences.

Matches are based on a search for the company name. Variations in the company name, such as acronyms, nicknames or alternate names may cause documents to be missed. The mention of a company name in a document may be incidental and does not necessarily indicate that the company has any relevance to the document. Company names that are common English words may erroneously match with text that is not referring to the company.

Not all agencies submit public comments to Regulations.gov. For a list of participating and non-participating agencies see here. Agencies that do submit to Regulations.gov have varying levels of accuracy and completeness.

Regulations and public comments can be downloaded in bulk here.

updated from Regulations.gov on September 27, 2011

The tables show occurrences of "Bristol-Myers Squibb" in public comments on proposed federal regulations.

  • Documents Submitted by the Organization
    • Submissions
    • Agency
    • Docket
    • Date
    • Toggle 1 FDA Draft Guidance for Industry on Non-Penicillin Beta-Lactam Risk Assessment: A CGMP Framework; Availability 2011
    • Toggle 1 FDA Agency Information Collection Activities; Proposed Collection; Comment Request; Examination of Online Direct-to-Consumer Prescription Drug Promotion 2011
    • Toggle 1 NLRB Proposed rule amending representation-case procedures 2011
  • Mentions in Document Text
    • Mentions
    • Agency
    • Docket
    • Date
    • Toggle 3 EPA Human Studies Review Board Meeting 2011
    • Toggle 2 FDA Bristol-Myers Squibb Co. et al.; Withdrawal of Approval of 70 New Drug Applications and 97 Abbreviated New Drug Applications - CLOSED 2011
    • Toggle 1 FDA Declare That the Drug Products, Metformin Hydrochloride Chewable Tables, 500 mg, 850 mg, and 1 g are Suitable for Consideration in an Abbreviated New Drug Application (ANADA) 2011
    • Toggle 1 FDA Advisory Committee, Workshops, and Conferences Notices Various Meeting Notices (eg., Task Force Meeting, etc.) 2011
    • Toggle 1 OCC Credit Risk Retention by Securitizers 2011
    • Toggle 1 SEC Whistleblower Provisions of the Securities Exchange Act 2011
    • Toggle 1 NLRB Proposed rule amending representation-case procedures 2011
    • Toggle 1 FDA Boston Scientific Corp. ION™ Paclitaxel-Eluting Coronary Stent System (Monorail and Over-the-Wire Systems)P100023; Approved 4/22/11 2011
    • Toggle 1 FDA Draft Guidance for Industry; Dietary Supplements: New Dietary Ingredient Notifications and Related Issues 2011
    • Toggle 1 FDA Agency Information Collection Activities; Proposed Collection; Comment Request; Data to Support Communications Usability Testing, as Used by The Food And Drung Administration 2011

Advisory Committees

1 person on 1 committee
Information

Data is based on disclosures required by the Federal Advisory Committee Act (FACA). Matches are based on the occurrence of the company name in the committee member affiliation. Variations in company names may cause some matches to be missed.

The table shows only the top 10 agencies. To search and download raw records from the complete dataset see the FACA data section.

covers through 2011

Table shows employees of "Bristol-Myers Squibb" that sat on federal advisory committees.

  • Agency
  • Representation
  • Toggle Department of the Treasury 1 person on 1 committee
View all advisory committee data for Bristol-Myers Squibb